Home
News
Features
Podcasts
Research
White Papers & Webcasts
Events
Technology
Supply Chain
Mergers & Acquisitions
Clinical Trials & Research
Policy & Regulation
Industry News
Toggle navigation
PharmaNewsIntelligence
Home
News
Features
Interviews
Podcasts
White Papers & Webcasts
Events
Technoloogy
Supply Chain
Mergers & Acquisitions
Clinical Trials & Research
Policy & Regulation
Industy News
PharmaNewsIntelligence
Pharmaceutical Acquisitions News
Pharmaceutical Acquisitions
Pharmaceutical Companies Made Acquisitions a Top Priority in 2019
November 22, 2019
by Kyle Murphy, PhD
By the midway point of 2019, more than $200 billion had exchanged hands, exceeding previous years of $198 billion and $178 in 2018 and 2017, respectively. And the recent closing of Bristol-Myers Squibb...
Recent Articles
FDA opens discussion on optimizing advisory committees to the public
Metformin use is associated with reduced cancer risk
NIH researchers develop AI tool for personalized oncology
EPA finalizes chemical plant clean air standards